The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA ™ (clesrovimab-cfor), ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

SEATTLE, WA / ACCESS Newswire / June 13, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ...

BURLINGTON, ON / ACCESS Newswire / June 13, 2025 / Safe 'N' Sound Environmental Services Ltd., a Burlington-based environmental remediation firm, has been recognized with the 2025 Consumer Choice ...

Kennedy Jr. announced Wednesday he's naming eight new advisers to serve on the Centers for Disease Control and Prevention's ...

Rep Kim Schrier, MD, (D-Wash.), said on X yesterday that some of the newly appointed ACIP replacements are anti-vaccine ...

After firing the former members of ACIP earlier this week, Kennedy has appointed eight new members to the vaccine advisory board – including some vaccine skeptics.

Overall, the United States has seen almost 1,200 measles cases this year, threatening the elimination status the country has held since 2000. Cases this year have almost topped the total in 2019, when ...